Delivery Order SPE2DB24D2100-SPE2DB25FBFJE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,389.36 to AmerisourceBergen Drug Corp on July 18, 2025, for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 21, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4ml units. This contract, valued at $3,539.90, represents a firm fixed price delivery order with no set-aside designation, indicating competitive award. The contract is classified as a child contract and executed through AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $5,946.15 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4mL units. This non-competitive, firm fixed-price delivery order was awarded on August 8, 2025, with an ultimate completion date of August 11, 2025. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania facility, where the company maintains its corporate headquarters and serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $2,038.68 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Tetracaine 0.5% Steri-Unit Solution in 4 mL units, with an ultimate completion date of July 28, 2025. This contract award is not set-aside and utilizes firm fixed pricing under a competitive delivery order arrangement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order valued at $1,582.65 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution 4ML, a pharmaceutical product for military medical supply needs. This competitively awarded, firm fixed price contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was used for this procurement. This...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,101.01 firm fixed-price delivery order is for the supply of 4565786481 - Tetracaine 1% (20 mg/2 ml) vials, with a period of performance through September 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
- This federal contract award, with an identification number of SPE2DB24D2205|SPE2DB24FDTRX, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,815.26 firm fixed-price delivery order is for the supply of Tetracaine 0.5% Steri-Unit Solution, a pharmaceutical product. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tetracaine 0.5% Steri-Unit Solution, a medical product, with a ceiling value of $1,395.69 and a period of performance ending on July 8, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,185,954 units of Tetracaine 0.5% Steri-Unit Solution 4ML to support military treatment programs and facilities. The contract has a ceiling value of $1,543.92 and a period of performance through April 8, 2024. Amerisourcebergen Drug Corp is also the prime contractor on an indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4 mL vials of 0.5% Tetracaine sterile solution. The $3,019.24 contract has an ultimate completion date of April 12, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFJEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,356.03 to AmerisourceBergen Drug Corp for Tetracaine 0.5% Steri-Unit Solution in 4 milliliter units. The contract was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025, and utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's broader federal pharmaceutical supply relationship with DLA. This award is a child contract issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999.999 billion through December 2026. AmerisourceBergen serves as a critical pharmaceutical distributor for federal medical procurement, supplying medications, vaccines, and medical supplies to military and veteran healthcare systems. The Tetracaine solution being procured under this delivery order supports DLA's medical supply chain requirements, with the company's portfolio encompassing specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/21/25 |